MedPath

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

Recruiting
Conditions
Amblyopia
Registration Number
NCT06429280
Lead Sponsor
Luminopia
Brief Summary

Amblyopia is the most prevalent cause of reduced monocular visual acuity in children and young adults, with estimates of prevalence ranging from 1% to 5%. The most common associated amblyogenic risk factors are uncorrected anisometropia, strabismus, or a combination of these. In addition to reduced visual acuity, amblyopic patients may also have measurable dysfunction of accommodation, fixation, binocularity, vergence, reading fluency, depth perception, and contrast sensitivity.

For the first time since the incorporation of atropine penalization into amblyopia management, physicians can now offer Luminopia, an FDA-approved dual action dichoptic treatment, to patients with amblyopia. Since the product became commercially available in November 2022, the number of patients on Luminopia therapy continues to grow. This presents a unique opportunity to gather real world evidence from a large number of patients, representative of how ophthalmologists and optometrists are applying this novel treatment in the real world. A registry of the clinical data associated with Luminopia treatment, with IRB oversight, will provide answers to key scientific questions using a large dataset.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Have a diagnosis of amblyopia
  • Have undergone or currently undergoing Luminopia treatment for a minimum of 12 weeks
Exclusion Criteria

-Have participated in prior Luminopia clinical trials

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence with Luminopia treatment3, 6,12, 24 months

Adherence with Luminopia treatment

Durability of Visual Acuity results post-treatment cessation3, 6,12, 24 months

Durability of Visual Acuity results post-treatment cessation

Change in Visual Acuity from baseline to consecutive visits3, 6,12, 24 months

Change in Visual Acuity from baseline to consecutive visits

Duration of Visual Acuity treatment and number of follow-up visits3, 6,12, 24 months

Duration of Visual Acuity treatment and number of follow-up visits

Change in Stereoacuity from baseline to consecutive visits3, 6,12, 24 months

Change in Stereoacuity from baseline to consecutive visits

Secondary Outcome Measures
NameTimeMethod
Visual Acuity analyses will also be conducted by Adherence to Treatment3, 6,12, 24 months

Visual Acuity analyses will also be conducted by Adherence to Treatment

Visual Acuity analyses will also be conducted by Prior Treatment3, 6,12, 24 months

Visual Acuity analyses will also be conducted by Prior Treatment

Visual Acuity Analyses will also be conducted by Age3, 6,12, 24 months

Visual Acuity Analyses will also be conducted by Age

Visual Acuity analyses will also be conducted by Amblyopia Type3, 6,12, 24 months

Visual Acuity analyses will also be conducted by Amblyopia Type

Visual Acuity analyses will also be conducted by Severity (Baseline Visual Acuity)3, 6,12, 24 months

Visual Acuity analyses will also be conducted by Severity (Baseline Visual Acuity)

Visual Acuity Analyses will also be conducted by Prescribed Dose3, 6,12, 24 months

Visual Acuity Analyses will also be conducted by Prescribed Dose

Visual Acuity analyses will also be conducted by Baseline Angle of Deviation3, 6,12, 24 months

Visual Acuity analyses will also be conducted by Baseline Angle of Deviation

Trial Locations

Locations (13)

Sansum Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Santa Barbara, California, United States

Lurie Children's Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Family Focus Eye Care

๐Ÿ‡บ๐Ÿ‡ธ

Gainesville, Florida, United States

Eye Physicians of Central Florida

๐Ÿ‡บ๐Ÿ‡ธ

Maitland, Florida, United States

Riley Children's Hospital at IU Health

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Nevada Eye Physicians

๐Ÿ‡บ๐Ÿ‡ธ

Las Vegas, Nevada, United States

Honolulu Eye Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Honolulu, Hawaii, United States

UCSF Benioff Children's Physicians

๐Ÿ‡บ๐Ÿ‡ธ

San Ramon, California, United States

Children's Eye Institute of Savannah

๐Ÿ‡บ๐Ÿ‡ธ

Savannah, Georgia, United States

Okaloosa Ophthalmology

๐Ÿ‡บ๐Ÿ‡ธ

Crestview, Florida, United States

Concord Eye Center

๐Ÿ‡บ๐Ÿ‡ธ

Concord, New Hampshire, United States

Children's Hospital Of Philadelphia

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Pediatric Eye Specialist

๐Ÿ‡บ๐Ÿ‡ธ

Fort Worth, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath